Skip to main content
ATAI Life Sciences N.V. logo

ATAI Life Sciences N.V. — Investor Relations & Filings

Listed
Ticker · ATAI ISIN · NL0015000DX5 LEI · 391200Z8UWPJSNBNCA11 US Manufacturing
Open in API
Filings indexed 319 across all filing types
Latest filing 2026-03-20 Regulatory Filings
Country NL Netherlands
Listing US ATAI

About ATAI Life Sciences N.V.

https://atai.life/

AtaiBeckley is a clinical-stage biopharmaceutical company focused on developing innovative treatments for mental health disorders. Following a strategic combination with Beckley Psytech, the company advances a pipeline of psychedelic-inspired therapies, including hallucinogens and entactogens. Its mission is to address significant unmet needs in mental health by creating effective, rapid-acting, and convenient evidence-based treatments. The company targets a range of psychiatric conditions, such as depression and schizophrenia, with the goal of transforming patient outcomes on a large scale.

Recent filings

Filing Released Lang Actions
144 - Atai Beckley N.V. (0001840904) (Subject)
Regulatory Filings
2026-03-20 English
15-12G
Regulatory Filings Classification · 100% confidence The document is a Form 15 filed with the SEC, titled 'Certification and Notice of Termination of Registration under Section 12(g) of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports under Sections 13 and 15(d)'. It announces the termination of registration and suspension of reporting duties due to a merger and corporate conversion. The document is short (2207 characters) and serves as a regulatory notice rather than a financial report or detailed filing. It does not contain financial statements or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and certifications that do not fit other categories.
2025-12-30 English
POSASR
Regulatory Filings Classification · 95% confidence The document is a Post-Effective Amendment No. 1 to a Form S-3 Registration Statement filed with the SEC. It relates to deregistration of unsold securities following a corporate redomiciliation transaction. The document is regulatory in nature, dealing with securities registration and deregistration, and does not contain financial statements or detailed financial data. It is not a report like an Annual Report or Interim Report, nor is it a presentation or earnings release. It is a formal regulatory filing related to securities registration status and compliance with SEC rules. Therefore, it fits best under Regulatory Filings (RNS). The document length is about 5955 characters, which is consistent with a regulatory filing rather than a full financial report.
2025-12-30 English
S-8 POS
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement (Post-Effective Amendment No. 1) filed with the SEC by AtaiBeckley Inc. It pertains to the registration of securities under employee benefit plans, specifically equity incentive plans. The document includes detailed legal and corporate information about the registration, indemnification provisions, incorporation of prior filings by reference, and exhibits related to the registration statement. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration under the Securities Act of 1933. The presence of SEC form identifiers (Form S-8), registration numbers, and legal descriptions confirms this classification. Therefore, the document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2025-12-30 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text mentions a prospectus supplement related to common shares registration and includes legal opinions as exhibits. There is no detailed financial data, earnings information, or comprehensive report content. The document is relatively short (3620 characters) and serves as a notification of a filing event rather than a full financial or management report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2025-12-05 English
424B7
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(7) related to a registration statement for common shares. It discusses registration rights, selling securityholders, and details about the offering of shares following an acquisition. The document references SEC filings such as Form 10-K, 10-Q, and proxy statements but is itself a prospectus supplement, which is a disclosure document used in securities offerings to provide details about the offering and the securities being registered. This type of document is best classified under Capital/Financing Update (CAP) because it relates to the registration and offering of shares, capital raising, and financing activities. It is not an annual report, earnings release, or other financial report, nor is it a proxy statement or voting results announcement. The length and content confirm it is a detailed offering document, not a brief announcement or a report publication notice.
2025-12-05 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.